Orally active bronchospasmolytic compounds

Chemistry of carbon compounds – Miscellaneous organic carbon compounds – C-metal

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

2605706, C07C 9326, C07C 9134

Patent

active

040112586

ABSTRACT:
Novel compounds are disclosed having useful activity as bronchodilators of improved longevity of action and reduced incidence of side effects. These compounds are described by the formula: ##STR1## wherein R.sub.1 is a member of the class consisting of tertiary butyl and cyclobutyl, and R.sub.2 is a hydrogen or 2 to 5 carbon atom acyl radical, and pharmaceutically acceptable salts thereof. The activity of these compounds is compared to previously known bronchodilators such as 1-(3', 5'-dihydroxyphenyl)-2-(isopropylamino)-ethanol, having the common name orciprenaline, and 1-(3', 4'-dihydroxyphenyl-2-isopropylamino-ethanol, having the common name isoprenaline.

REFERENCES:
patent: 3180887 (1965-04-01), Zolss et al.
Moed et al., Rec. Trav. Chim. Pay Bus. 71, 933 (1952).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Orally active bronchospasmolytic compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Orally active bronchospasmolytic compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Orally active bronchospasmolytic compounds will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1406094

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.